We all play a role in biomedical progress. Just by paying your insurance premiums—and saving for retirement—you are enabling grand quests to vanquish many diseases. In these videos and articles, hear from the scientists and executives doing that work. These are your quests, too. Thank you for supporting them.
Featuring:
Blake Aftab—Chief Science Officer, Adicet Bio
Aoife Brennan—President & Chief Executive Officer, Climb Bio
Paul Hastings—Chief Executive Officer, Nkarta Therapeutics
Jeb Keiper—Chief Executive Officer, Nimbus Therapeutics
Jonathan Montagu—Chief Executive Officer HotSpot Therapeutics
Joel Barrish—Chief Executive Officer, Conveyor Therapeutics
Laura Shawver—Chief Executive Officer, Capstan Therapeutics
Featuring:
Blake Aftab—Chief Science Officer, Adicet Bio
Aoife Brennan—President & Chief Executive Officer, Climb Bio
Paul Hastings—Chief Executive Officer, Nkarta Therapeutics
Jeb Keiper—Chief Executive Officer, Nimbus Therapeutics
Jonathan Montagu—Chief Executive Officer HotSpot Therapeutics
Joel Barrish—Chief Executive Officer, Conveyor Therapeutics
Laura Shawver—Chief Executive Officer, Capstan Therapeutics
Cambridge is home to the world's most innovative biotech companies. Resident Neil Kairen explains the importance of this industry and suggests explanations for why so many misunderstand its value.
Researchers in Pennsylvania are working on a cure for Parkinson’s. Price controls threaten their progress.
A company in Virginia is working on a vaccine to protect babies from rotavirus and norovirus.
